CR Sanjiu(000999) 金融界·2025-04-16 07:42Group 1 - The vitamin sector experienced a decline of 1.97% on April 16, with a net outflow of 183 million yuan from main funds, where 4 stocks rose and 26 stocks fell [1] - The companies with the highest net outflow of main funds included China Resources Sanjiu (588.49 million yuan), Xingqi Eye Medicine (313.44 million yuan), Shengda Biology (188.84 million yuan), North China Pharmaceutical (183.74 million yuan), and Nengte Technology (181.81 million yuan) [1] Group 2 - The top stock by net inflow was Huayuan Biological, with a net inflow of 32.28 million yuan and a price increase of 0.29% [2] - New Hec (21.80 yuan) saw a decline of 1.71% with a net inflow of 16.02 million yuan, while Brother Technology (4.02 yuan) experienced a significant drop of 6.07% with a net inflow of 9.80 million yuan [2] - Other notable declines included Zhejiang Medicine (-1.23%), Hendi Pharmaceutical (-1.37%), and Weixin Kang (-1.80%), all showing negative net inflows [2]